Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Psilocybin, the principal indole alkaloid of Psilocybe mushrooms, is currently undergoing clinical trials as a medication against treatment‐resistant depression and major depressive disorder. The psilocybin supply for pharmaceutical purposes is met by synthetic chemistry. We replaced the problematic phosphorylation step during synthesis with the mushroom kinase PsiK. This enzyme was biochemically characterized and used to produce one gram of psilocybin from psilocin within 20 minutes. We also describe a pilot‐scale protocol for recombinant PsiK that yielded 150 mg enzyme in active and soluble form. Our work consolidates the simplicity of tryptamine chemistry with the specificity and selectivity of enzymatic catalysis and helps provide access to an important drug at potentially reasonable cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim
Hofmann, A., Heim, R., Brack, A., & Kobel, H. (1958) · Experientia · doi:10.1007/bf02159243 · Cited by 282
Research works printed but not linked: 24
- 10.1002/hlca.19590420518 · DOI · Paper page
- 10.1021/acschemneuro.8b00186 · DOI · Paper page
- 10.1007/s13311-017-0542-y · DOI · Paper page
- 10.1055/s-1999-3490 · DOI
- 10.1021/np030059u · DOI · Paper page
- 10.1016/j.tet.2016.03.007 · DOI
- 10.3987/COM-99-8492 · DOI
- 10.1016/j.tet.2009.09.050 · doi:10.1016/j.tet.2009.09.050
- 10.1021/ol0341039 · DOI
- 10.1055/s-0039-1691565 · DOI
- 10.1002/anie.201705489 · DOI · Paper page
- 10.1002/ange.201705489 · DOI
- 10.1002/evl3.42 · DOI · Paper page
- 10.1016/j.ymben.2018.05.014 · DOI
- 10.1016/j.ymben.2019.09.009 · DOI
- 10.1002/anie.201910175 · DOI · Paper page
- 10.1186/1472-6807-7-70 · DOI
- 10.1016/j.bioorg.2011.11.001 · DOI · Paper page
- 10.1007/BF00226892 · DOI
- 10.1021/ja01652a113 · DOI
- 10.1002/chem.201801047 · DOI · Paper page
- 10.1021/acs.jnatprod.7b00407 · DOI · Paper page
- Fricke J., 2019, ChemBioChem, 20
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
Cited by
Van Court, R. C., Wiseman, M. S., Meyer, K. W., Ballhorn, D. J., Amses, K. R., Slot, J. C., Dentinger, B. T. M., Garibay-Orijel, R., & Uehling, J. K. (2022) · Fungal Biology · doi:10.1016/j.funbio.2022.01.003 · Cited by 94
Pepe, M., Hesami, M., de la Cerda, K. A., Perreault, M. L., Hsiang, T., & Jones, A. M. P. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108247 · Cited by 36
Cohen, J., Sulimani, L., Procaccia, S., Lerenthal, Y., Milay, L., Taran, I., Shapira, A., & Meiri, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-97710-z · Cited by 8
Selective Phosphorylation of Phenols and Benzenediols by the Kinase PsiK and Variants Thereof
Kim, A., Morato, N. M., Saha, P., Eyimegwu, P. N., Niyaz, A. A., Huang, R., Cooks, R. G., Phelan, R. M., & Lewis, J. C. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202503538 · Cited by 7
Metadata
- Authors
- Fricke, J., Kargbo, R., Regestein, L., Lenz, C., Peschel, G., Rosenbaum, M. A., Sherwood, A., & Hoffmeister, D.
- Venue
- Chemistry – A European Journal
- Publisher
- Wiley
- Published
- 2020-06-08
- Volume
- 26
- Issue
- 37
- Pages
- 8281-8285
- ISSN
- 0947-6539 (ISSN-L)
- 1521-3765
- OpenAlex
- W3007311584
- Cited by
- 46
- References
- 2
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Deutsche Forschungsgemeinschaft (HO2515/7-1, SFB1127)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. https://app.cochat.ai/papers/10.1002/chem.202000134
- The paper
- Fricke, J., Kargbo, R., Regestein, L., Lenz, C., Peschel, G., Rosenbaum, M. A., Sherwood, A., & Hoffmeister, D. (2020). Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. Chemistry – A European Journal. https://doi.org/10.1002/chem.202000134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.